6:33 PM
 | 
Dec 17, 2012
 |  BC Extra  |  Company News

Bio-Rad to acquire MorphoSys' AbD Serotec division

Bio-Rad Laboratories Inc. (NYSE:BIO) will acquire the AbD Serotec research and diagnostic antibody division of MorphoSys AG (Xetra:MOR; Pink:MPSYF)...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >